Although the clinical capacity of the short TE PRESS acquisition method is limited by the high false positive detection rate, it may be applicable within a research setting, aimed at evaluating the role of IDH mutation in development and progression of glioma pathology. Here, IDH2 is linked to central nervous system cancer.